REVICKI DA, OSOBA D, FAIRCLOUGH D, BAROFSKY I, BERZON R, LEIDY NK,R...

2.

Revicki DA, Osoba D, Fairclough D, Barofsky I, Berzon R, Leidy NK,

Rothman M: Recommendations on health-related quality of

however be useful for the detection of non-compliant

life research to support labeling and promotional claims in

patients. A regular intake of the prescribed immunosup-

the United States. Qual Life Res 2000, 9:887-900.

pressive drugs is key to prevent graft rejection in these sub-